Log In
BCIQ
Print this Print this
 

ALXN5500

  Manage Alerts
Collapse Summary General Information
Company Alexion Pharmaceuticals Inc.
DescriptionComplement inhibitor
Molecular Target
Mechanism of ActionComplement inhibitor; Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationParoxysmal nocturnal hemoglobinuria (PNH)
Indication DetailsTreat paroxysmal nocturnal hemoglobinuria (PNH)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today